Ghana Building 2,000-Acre Pharmaceutical Hub for 20,000 Jobs

Ghana is turning 2,000 acres of land into a pharmaceutical manufacturing powerhouse that could transform how West Africa produces medicines.

The government has identified a site in the Shai-Osudoku District for a comprehensive pharmaceutical industrial park. This won't be just another factory complex but a complete ecosystem with roads, electricity, water treatment facilities, and even housing for workers.

The project already has an anchor investor and a pipeline of interested tenants from India, China, and the United States. Ghanaian health professionals living abroad have also expressed interest in joining the venture.

Kafui Linda Abbah-Foli, Head of Project Development for Ghana's 24-Hour Economy initiative, announced the plans at the 2026 China-West Africa Medical and Health Industry Expo in Accra. She emphasized that the park would address major hurdles facing manufacturers, particularly access to land and reliable infrastructure.

The need is clear and urgent. Ghana currently imports 70% of its pharmaceutical needs, including most of the active ingredients used even in local production. This dependence became painfully obvious during the COVID-19 pandemic when global supply chains struggled.

The new park will support the entire pharmaceutical value chain. It will house facilities for medicine manufacturing, medical device production, herbal medicine development, and research labs all in one integrated location.

The Ripple Effect

The project's impact extends far beyond medicine bottles. Within five years, the park aims to support up to 20,000 people through direct employment and related businesses.

The development will include a complete township with housing facilities, creating a thriving community around health innovation. Local communities won't just watch from the sidelines either.

Ghana has introduced a participatory land acquisition model where traditional authorities and landowners become shareholders. They'll earn dividends and rental income, ensuring the people who live there benefit directly from the economic opportunities.

The timing matters more than ever as Ghana faces rising rates of non-communicable diseases like diabetes and stroke. Producing these medications locally could significantly reduce pressure on the national health budget while ensuring reliable access to essential treatments.

Pre-feasibility studies are already complete, with full feasibility assessments and master planning expected after project development wraps up by year's end. The initiative positions Ghana not just as a consumer of health products but as a manufacturing and innovation hub for the entire region.

Twenty thousand lives changed, millions of patients served with locally produced medicines, and a nation building resilience for the next health emergency.